Depression and Anxiety
- 1 September 2006
- journal article
- research article
- Published by Wolters Kluwer Health in The Cancer Journal
- Vol. 12 (5) , 388-397
- https://doi.org/10.1097/00130404-200609000-00008
Abstract
Anxiety and depression are common in patients with cancer and in palliative care settings. These symptoms can be reactive to the illness or can be related to the direct physiologic effects of the disease or to drug therapies. Effective treatment of these symptoms includes both psychopharmacoiogic and psychotherapeutic approaches. The newer antidepressants, anxiolytics, and hypnotics are better tolerated and can be continued safely if necessary, or they can be reduced and discontinued as symptoms improve.Keywords
This publication has 22 references indexed in Scilit:
- Prevalence of Depression in Patients With CancerJNCI Monographs, 2004
- Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapyBrain, Behavior, and Immunity, 2004
- Relations between Desire for Early Death, Depressive Symptoms and Antidepressant Prescribing in Terminally Ill Patients with CancerJournal of the Royal Society of Medicine, 2002
- Depression in advanced disease: a systematic review. Part 1: Prevalence and case findingPalliative Medicine, 2002
- Depression Is a Risk Factor for Noncompliance With Medical TreatmentArchives of internal medicine (1960), 2000
- The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analysesBritish Journal of Cancer, 1999
- Breakthrough pain: characteristics and impact in patients with cancer painPain, 1999
- Depression, Hopelessness, and Suicidal Ideation in the Terminally IllPsychosomatics, 1998
- Diagnosis of major depression in cancer patients according to four sets of criteriaAmerican Journal of Psychiatry, 1990
- The Prevalence of Psychiatric Disorders Among Cancer PatientsJAMA, 1983